Kexing Biopharm Co., Ltd. (SHA:688136)
34.22
+0.58 (1.72%)
Jan 23, 2026, 3:00 PM CST
85.27% (1Y)
| Market Cap | 6.66B |
| Revenue (ttm) | 1.52B |
| Net Income (ttm) | 125.57M |
| Shares Out | 198.11M |
| EPS (ttm) | 0.62 |
| PE Ratio | 54.28 |
| Forward PE | 53.82 |
| Dividend | 0.08 (0.24%) |
| Ex-Dividend Date | n/a |
| Volume | 2,003,861 |
| Average Volume | 2,894,128 |
| Open | 33.60 |
| Previous Close | 33.64 |
| Day's Range | 33.52 - 34.27 |
| 52-Week Range | 17.71 - 63.99 |
| Beta | 0.79 |
| RSI | 48.15 |
| Earnings Date | Mar 28, 2026 |